{"id":"https://openalex.org/W2098577478","doi":"https://doi.org/10.1586/ecp.10.120","title":"Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity","display_name":"Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity","alternate_titles":[],"publication_year":2010,"publication_date":"2010-11-01","ids":{"openalex":"https://openalex.org/W2098577478","doi":"https://doi.org/10.1586/ecp.10.120","mag":"2098577478","pmid":"https://pubmed.ncbi.nlm.nih.gov/22111779"},"language":"en","primary_location":{"id":"doi:10.1586/ecp.10.120","doi":"https://doi.org/10.1586/ecp.10.120","is_oa":false,"landing_page_url":"https://doi.org/10.1586/ecp.10.120","pdf_url":null,"source":{"id":"https://openalex.org/S102962966","display_name":"Expert Review of Clinical Pharmacology","issn_l":"1751-2433","issn":["1751-2433","1751-2441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2098577478"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112355303","display_name":"Kathleen Knights","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169541294","display_name":"Flinders University","ror":"https://ror.org/01kpzv902","country_code":"AU","type":"education","lineage":["https://openalex.org/I169541294"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kathleen M Knights","raw_affiliation_strings":["Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia","Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia; kathie.knights@flinders.edu.au"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia","institution_ids":["https://openalex.org/I169541294"]},{"raw_affiliation_string":"Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia; kathie.knights@flinders.edu.au","institution_ids":["https://openalex.org/I169541294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057645839","display_name":"Arduino Aleksander Mangoni","orcid":"https://orcid.org/0000-0001-8699-1412","observed_orcids":["https://orcid.org/0000-0001-8699-1412"]},"institutions":[{"id":"https://openalex.org/I195460627","display_name":"University of Aberdeen","ror":"https://ror.org/016476m91","country_code":"GB","type":"education","lineage":["https://openalex.org/I195460627"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Arduino A Mangoni","raw_affiliation_strings":["School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK; School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK; School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK","institution_ids":["https://openalex.org/I195460627"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008901409","display_name":"John O. Miners","orcid":"https://orcid.org/0000-0001-9555-9453","observed_orcids":["https://orcid.org/0000-0001-9555-9453"]},"institutions":[{"id":"https://openalex.org/I169541294","display_name":"Flinders University","ror":"https://ror.org/01kpzv902","country_code":"AU","type":"education","lineage":["https://openalex.org/I169541294"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"John O Miners","raw_affiliation_strings":["Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia; Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia; Department of Clinical Pharmacology, Flinders University, Bedford Park, Adelaide, 5042 Australia","institution_ids":["https://openalex.org/I169541294"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7931,"has_fulltext":false,"cited_by_count":140,"citation_normalized_percentile":{"value":0.82078349,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"3","issue":"6","first_page":"769","last_page":"776"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.6119999885559082},{"id":"https://openalex.org/keywords/cyclooxygenase-2","display_name":"cyclooxygenase-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cox-selectivity","display_name":"COx selectivity","score":0.8460000157356262},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6290000081062317},{"id":"https://openalex.org/keywords/thromboxane-a2","display_name":"thromboxane A2","score":0.9229999780654907},{"id":"https://openalex.org/keywords/prostacyclin","display_name":"prostacyclin","score":0.9800000190734863},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.7260000109672546},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.8240000009536743},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.9549999833106995},{"id":"https://openalex.org/keywords/anti-inflammatory-mechanism","display_name":"anti-inflammatory mechanism","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7459176182746887},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6773176789283752},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6335986852645874},{"id":"https://openalex.org/C2781128415","wikidata":"https://www.wikidata.org/wiki/Q412050","display_name":"Prostacyclin","level":2,"score":0.5828516483306885},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.545520007610321},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4575805068016052},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.417322039604187},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2975265383720398},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.16536012291908264},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10460665822029114},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07691085338592529},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1586/ecp.10.120","doi":"https://doi.org/10.1586/ecp.10.120","is_oa":false,"landing_page_url":"https://doi.org/10.1586/ecp.10.120","pdf_url":null,"source":{"id":"https://openalex.org/S102962966","display_name":"Expert Review of Clinical Pharmacology","issn_l":"1751-2433","issn":["1751-2433","1751-2441"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:22111779","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22111779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:dspace.flinders.edu.au:2328/33052","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2328/33052","pdf_url":null,"source":{"id":"https://openalex.org/S4306401120","display_name":"Flinders Academic Commons (Flinders University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169541294","host_organization_name":"Flinders University","host_organization_lineage":["https://openalex.org/I169541294"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:fac.flinders.edu.au:2328/33052","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2328/33052","pdf_url":null,"source":{"id":"https://openalex.org/S4306401120","display_name":"Flinders Academic Commons (Flinders University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169541294","host_organization_name":"Flinders University","host_organization_lineage":["https://openalex.org/I169541294"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W62728581","https://openalex.org/W154881089","https://openalex.org/W1494920110","https://openalex.org/W1595797530","https://openalex.org/W1902187490","https://openalex.org/W1921815852","https://openalex.org/W1964665460","https://openalex.org/W1964786466","https://openalex.org/W1968439879","https://openalex.org/W1969989200","https://openalex.org/W1990604933","https://openalex.org/W1999243320","https://openalex.org/W2002840016","https://openalex.org/W2008574207","https://openalex.org/W2010311152","https://openalex.org/W2010916187","https://openalex.org/W2014845948","https://openalex.org/W2018441825","https://openalex.org/W2018728665","https://openalex.org/W2030850720","https://openalex.org/W2032627156","https://openalex.org/W2038410983","https://openalex.org/W2049772907","https://openalex.org/W2049908664","https://openalex.org/W2068573594","https://openalex.org/W2076419051","https://openalex.org/W2076744535","https://openalex.org/W2089121403","https://openalex.org/W2090431078","https://openalex.org/W2094761607","https://openalex.org/W2096874183","https://openalex.org/W2115350007","https://openalex.org/W2123175521","https://openalex.org/W2124039416","https://openalex.org/W2126853519","https://openalex.org/W2129969134","https://openalex.org/W2148744880","https://openalex.org/W2157724147","https://openalex.org/W2158960911","https://openalex.org/W2164162242","https://openalex.org/W2164397284","https://openalex.org/W2172189283","https://openalex.org/W2240026871","https://openalex.org/W2440780529","https://openalex.org/W2576830953","https://openalex.org/W4239622936","https://openalex.org/W4251183219"],"related_works":["https://openalex.org/W2028770303","https://openalex.org/W2321877600","https://openalex.org/W2038410983","https://openalex.org/W2141068495","https://openalex.org/W1976974617","https://openalex.org/W2000588783","https://openalex.org/W4402830770","https://openalex.org/W184022295","https://openalex.org/W2084447650","https://openalex.org/W2019370793"],"abstract_inverted_index":{"The":[0],"hypothesis":[1],"that":[2,89],"the":[3,18,22,53,67,73,76,86,90,100,108,130,133,142],"anti-inflammatory":[4],"activity":[5,56],"of":[6,21,27,32,46,52,57,69,75,93,103,111,132,144],"NSAIDs":[7,94,145],"derives":[8],"from":[9,96,117],"COX":[10,37,70,137],"inhibition":[11,38,48],"is":[12,36,60],"well":[13],"established.":[14],"It":[15],"also":[16],"underpins":[17],"accepted":[19],"mechanism":[20],"gastrointestinal":[23],"and":[24,66,81,107,139],"renal":[25],"toxicity":[26,143],"NSAIDs.":[28,58],"However,":[29],"in":[30,99,118,129,135,146],"terms":[31],"NSAID-induced":[33],"cardiovascular":[34,91],"toxicity,":[35],"then":[39],"guilty":[40],"by":[41],"association?":[42],"Multiple":[43],"experimental":[44],"models":[45,120],"COX-1/COX-2":[47],"have":[49],"enabled":[50],"ranking":[51],"relative":[54],"inhibitory":[55],"Inhibition":[59],"expressed":[61],"as":[62,72],"an":[63,97],"IC(50)":[64,77,125],"value":[65,78],"index":[68],"selectivity":[71,138],"ratio":[74],"for":[79],"COX-2":[80],"COX-1.":[82],"These":[83],"data":[84],"informed":[85],"'imbalance":[87],"hypothesis'":[88],"risk":[92],"results":[95],"imbalance":[98],"detrimental":[101],"actions":[102,110],"COX-1-derived":[104],"thromboxane":[105],"A(2)":[106],"beneficial":[109],"COX-2-derived":[112],"prostacyclin":[113],"(PGI(2)).":[114],"Data":[115],"derived":[116],"vitro":[119],"used":[121],"to":[122],"generate":[123],"NSAID":[124],"values":[126],"are":[127],"discussed":[128],"context":[131],"difficulties":[134],"defining":[136],"hence":[140],"understanding":[141],"current":[147],"clinical":[148],"use.":[149]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2098577478","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":18},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
